Literature DB >> 1496988

Dystrophin in frameshift deletion patients with Becker muscular dystrophy.

S B Gangopadhyay1, T G Sherratt, J Z Heckmatt, V Dubowitz, G Miller, M Shokeir, P N Ray, P N Strong, R G Worton.   

Abstract

In a previous study we identified 14 cases with Duchenne muscular dystrophy (DMD) or its milder variant, Becker muscular dystrophy (BMD), with a deletion of exons 3-7, a deletion that would be expected to shift the translational reading frame of the mRNA and give a severe phenotype. We have examined dystrophin and its mRNA from muscle biopsies of seven cases with either mild or intermediate phenotypes. In all cases we detected slightly lower-molecular-weight dystrophin in 12%-15% abudance relative to the normal. By sequencing amplified mRNA we have found that exon 2 is spliced to exon 8, a splice that produces a frameshifted mRNA, and have found no evidence for alternative splicing that might be involved in restoration of dystrophin mRNA reading frame in the patients with a mild phenotype. Other transcriptional and posttranscriptional mechanisms such as cryptic promoter, ribosomal frameshifting, and reinitiation are suggested that might play some role in restoring the reading frame.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1496988      PMCID: PMC1682710     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  32 in total

Review 1.  RNA editing in trypanosomes: is there a message?

Authors:  R Benne
Journal:  Trends Genet       Date:  1990-06       Impact factor: 11.639

Review 2.  Genetics of Duchenne muscular dystrophy.

Authors:  R G Worton; M W Thompson
Journal:  Annu Rev Genet       Date:  1988       Impact factor: 16.830

Review 3.  The Duchenne dystrophy story: from phenotype to gene and potential treatment.

Authors:  V Dubowitz
Journal:  J Child Neurol       Date:  1989-10       Impact factor: 1.987

4.  Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy.

Authors:  S B Malhotra; K A Hart; H J Klamut; N S Thomas; S E Bodrug; A H Burghes; M Bobrow; P S Harper; M W Thompson; P N Ray
Journal:  Science       Date:  1988-11-04       Impact factor: 47.728

5.  Dystrophin is tightly associated with the sarcolemma of mammalian skeletal muscle fibers.

Authors:  E E Zubrzycka-Gaarn; O F Hutter; G Karpati; H J Klamut; D E Bulman; R S Hodges; R G Worton; P N Ray
Journal:  Exp Cell Res       Date:  1991-01       Impact factor: 3.905

6.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

7.  A comparison between mammalian and avian fast skeletal muscle alkali myosin light chain genes: regulatory implications.

Authors:  P Daubas; B Robert; I Garner; M Buckingham
Journal:  Nucleic Acids Res       Date:  1985-07-11       Impact factor: 16.971

8.  An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus.

Authors:  A P Monaco; C J Bertelson; S Liechti-Gallati; H Moser; L M Kunkel
Journal:  Genomics       Date:  1988-01       Impact factor: 5.736

9.  Differentiation of Duchenne and Becker muscular dystrophy phenotypes with amino- and carboxy-terminal antisera specific for dystrophin.

Authors:  D E Bulman; E G Murphy; E E Zubrzycka-Gaarn; R G Worton; P N Ray
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

10.  How 'hidden' reading frames are expressed.

Authors:  R Cattaneo
Journal:  Trends Biochem Sci       Date:  1989-05       Impact factor: 13.807

View more
  21 in total

1.  Identification of seven novel cryptic exons embedded in the dystrophin gene and characterization of 14 cryptic dystrophin exons.

Authors:  Zhujun Zhang; Yasuaki Habara; Atsushi Nishiyama; Yoshinobu Oyazato; Mariko Yagi; Yasuhiro Takeshima; Masafumi Matsuo
Journal:  J Hum Genet       Date:  2007-06-20       Impact factor: 3.172

2.  Alternative splicing of dystrophin exon 4 in normal human muscle.

Authors:  S Torelli; F Muntoni
Journal:  Hum Genet       Date:  1996-04       Impact factor: 4.132

3.  Clinical Utility Gene Card for: Becker muscular dystrophy.

Authors:  David Coote; Mark R Davis; Macarena Cabrera; Merrilee Needham; Nigel G Laing; Kristen J Nowak
Journal:  Eur J Hum Genet       Date:  2018-02-21       Impact factor: 4.246

4.  A 400-kb tandem duplication within the dystrophin gene leads to severe Becker muscular dystrophy.

Authors:  R Gold; W Kress; T Bettecken; H Reichmann; C R Müller
Journal:  J Neurol       Date:  1994-03       Impact factor: 4.849

5.  Diagnostic Accuracy of Phenotype Classification in Duchenne and Becker Muscular Dystrophy Using Medical Record Data1.

Authors:  Jennifer G Andrews; Molly M Lamb; Kristin Conway; Natalie Street; Christina Westfield; Emma Ciafaloni; Dennis Matthews; Christopher Cunniff; Shree Pandya; Deborah J Fox
Journal:  J Neuromuscul Dis       Date:  2018

6.  Use of epitope libraries to identify exon-specific monoclonal antibodies for characterization of altered dystrophins in muscular dystrophy.

Authors:  T M Nguyen; G E Morris
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

7.  Mild deficiency of dystrophin-associated proteins in Becker muscular dystrophy patients having in-frame deletions in the rod domain of dystrophin.

Authors:  K Matsumura; I Nonaka; F M Tomé; K Arahata; H Collin; F Leturcq; D Récan; J C Kaplan; M Fardeau; K P Campbell
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

8.  Exon skipping and translation in patients with frameshift deletions in the dystrophin gene.

Authors:  T G Sherratt; T Vulliamy; V Dubowitz; C A Sewry; P N Strong
Journal:  Am J Hum Genet       Date:  1993-11       Impact factor: 11.025

9.  Monoclonal antibodies against the muscle-specific N-terminus of dystrophin: characterization of dystrophin in a muscular dystrophy patient with a frameshift deletion of exons 3-7.

Authors:  T T Le; T M Nguyen; D R Love; T R Helliwell; K E Davies; G E Morris
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

10.  Deletions in the 5' region of dystrophin and resulting phenotypes.

Authors:  F Muntoni; P Gobbi; C Sewry; T Sherratt; J Taylor; S K Sandhu; S Abbs; R Roberts; S V Hodgson; M Bobrow
Journal:  J Med Genet       Date:  1994-11       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.